June 2025 On June 6, 2025, the European Medicines Agencys (EMA) safety committee concluded that Novo Nordisks semaglutide-containing drugsincluding the popular weight-loss drug Wegovy and diabetes treatments Ozempic and Rybelsusmay cause rare but serious cases of non-arteritic anterior ischemic optic neuropathy (NAION), a sudden and painless vision loss in one eye due to optic nerve damage
(II) Despite the intracellular GSH being significantly consumed in the cases stated in this review, it is difficult to completely deplete GSH via these strategies
These services allow us to create medications that are customized to meet the unique needs of each patient
Modulation of secondary metabolism and redox regulation by exogenously applied glutathione improves the shelf life of Capsicum annuum L
The SURMOUNT trials reported that approximately 4 to 7% of participants discontinued due to adverse events, depending on dose level
Recently, BCGs Center for Customer Insight (CCI) surveyed more than 1,500 GLP-1 users in nine markets